Coverage
-
June 09, 2016
A Maryland federal judge on Tuesday refused to grant Novartis Corp. attorneys' fees in an "exceptional" patent infringement case brought against it by a defunct nonpracticing entity in multidistrict litigation, saying the company failed to properly justify its request.
2 other articles on this case.
View all »